Beranda › Gagal Jantung › Washington › Seattle
Uji klinis Gagal Jantung di Seattle, WA
17 studi untuk Gagal Jantung mencari peserta di lokasi sekitar Seattle (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Menerima pesertaFase 3
- Virginia Mason Medical Center, Seattle
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Menerima pesertaFase 2
- Local Institution - 132, Seattle
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Menerima pesertaFase 2/3
- Seattle Children's Hospital-Cardiology/Fetal Therapy ( Site 0019), Seattle
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Menerima pesertaFase 2
- Swedish Heart & Vascular Institute, Advanced Cardiac Support Program, Seattle
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Menerima pesertaStudi observasional
- Virginia Mason Medical Center, Seattle
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Menerima pesertaFase 3
- Tenax Investigational Site, Seattle
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Menerima pesertaFase 3
- Swedish Medical Center_Seattle, Seattle
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Menerima pesertaFase 2
- Seattle Children's Hospital, Seattle
Assessment of CCM in HF With Higher Ejection Fraction
Menerima peserta
- Swedish Medical Center, Seattle
Repurposing Valsartan May Protect Against Pulmonary Hypertension
Menerima pesertaFase 2
- University of Washington Medical Center, Seattle
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Menerima pesertaFase 3
- University of Washington, Seattle
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Menerima peserta
- University of Washington Medical Center, Seattle
Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV
Menerima peserta
- University of Washington, Seattle
Left vs Left Randomized Clinical Trial
Menerima peserta
- University of Washington, Seattle
Cardiogenic Shock Working Group Registry
Menerima pesertaStudi observasional
- University of Washington Medical Center, Seattle
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Menerima pesertaFase 1/2
- University of Washington Medicine, Seattle
Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
Menerima peserta
- University of Washington Medical Center, Seattle
Uji klinis Gagal Jantung di kota lain
- New York City, NY51 studi
- Boston, MA44 studi
- Dallas, TX42 studi
- Houston, TX36 studi
- Cleveland, OH33 studi
- Chicago, IL31 studi
- Philadelphia, PA31 studi
- San Francisco, CA29 studi
- St. Louis, MO26 studi
- Durham, NC26 studi
- Kansas City, MO25 studi
- Atlanta, GA25 studi
Studi lain di Seattle
- Kanker Paru Non-Sel Kecil53 studi
- Kanker (semua jenis)49 studi
- Kanker Prostat42 studi
- Leukemia Mieloid Akut40 studi
- Kanker Payudara39 studi
- Kanker Metastatik39 studi
- Kanker Kolorektal34 studi
- Kanker Paru33 studi
- Kanker Ovarium30 studi
- Mieloma Multipel22 studi
- Sindrom Mielodisplastik21 studi
- Leukemia Limfoblastik Akut21 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.